|
|
||||||||


*
Center for Neurovirology, Department of Neurology, and Department of
Obstetrics and Gynecology, and
School of Public Health, MCP Hahnemann University, Philadelphia, PA 19102;
§
Section of Immunology, Department of Pediatrics, St. Christophers Hospital for Children, Philadelphia, PA 19134;
¶
Department of Obstetrics and Gynecology, Temple University School of Medicine, Philadelphia, PA 19140; and Divisions of
||
General Pediatrics,
#
Immunologic and Infectious Diseases, and
**
Neonatology, Childrens Hospital of Philadelphia, Philadelphia, PA 19104
To examine the protective role of cellular immunity in the vertical transmission of HIV, we analyzed HIV-specific IL-2 and CTL responses, as well as ß-chemokine expression in HIV-infected and uninfected infants of HIV+ mothers. Our results showed that HIV envelope (env) peptide-specific IL-2 responses associated with ß-chemokine production were detectable at birth in the majority of uninfected infants of HIV+ mothers. The responses falling to background before the infants were 1 yr old were rarely associated with HIV-specific CTL activity. Conversely, HIV-specific Th and CTL cellular responses were absent at birth in HIV-infected infants. Infants with AIDS-related symptoms exhibited undetectable or very low levels of HIV-specific cellular immunity during the first year of life, whereas those with a slowly progressive disease showed evidence of such immunity between their second and ninth month. The latter group of infected infants tested negative for plasma HIV RNA levels shortly after birth, suggesting lack of intrauterine exposure to HIV. The presence of HIV-specific Th responses at birth in uninfected newborns of HIV+ mothers, but absence of such activities in HIV-infected infants without evidence of intrauterine HIV infection, suggests that in utero development of HIV-specific Th responses associated with ß-chemokines could mediate nonlytic inhibition of infection during vertical transmission of HIV.
This article has been cited by other articles:
![]() |
D. B. Schramm, S. Meddows-Taylor, G. E. Gray, L. Kuhn, and C. T. Tiemessen Low Maternal Viral Loads and Reduced Granulocyte-Macrophage Colony-Stimulating Factor Levels Characterize Exposed, Uninfected Infants Who Develop Protective Human Immunodeficiency Virus Type 1-Specific Responses Clin. Vaccine Immunol., April 1, 2007; 14(4): 348 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meddows-Taylor, S. L. Donninger, M. Paximadis, D. B. Schramm, F. S. Anthony, G. E. Gray, L. Kuhn, and C. T. Tiemessen Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission J. Gen. Virol., July 1, 2006; 87(7): 2055 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barabitskaja, J. S. Foulke Jr., S. Pati, J. Bodor, and M. S. Reitz Jr. Suppression of MIP-1{beta} transcription in human T cells is regulated by inducible cAMP early repressor (ICER) J. Leukoc. Biol., February 1, 2006; 79(2): 378 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Lohman, J. A. Slyker, B. A. Richardson, C. Farquhar, J. M. Mabuka, C. Crudder, T. Dong, E. Obimbo, D. Mbori-Ngacha, J. Overbaugh, et al. Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants J. Virol., July 1, 2005; 79(13): 8121 - 8130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Goldman, L. R. Goldman, and D. A. Goldman What Caused the Epidemic of Pneumocystis Pneumonia in European Premature Infants in the Mid-20th Century? Pediatrics, June 1, 2005; 115(6): e725 - e736. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sun, S. F. Abdelwahab, G. K. Lewis, and A. Garzino-Demo Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization Int. Immunol., November 1, 2004; 16(11): 1623 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. O. TER KUILE, M. E. PARISE, F. H. VERHOEFF, V. UDHAYAKUMAR, R. D. NEWMAN, A. M. VAN EIJK, S. J. ROGERSON, and R. W. STEKETEE THE BURDEN OF CO-INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND MALARIA IN PREGNANT WOMEN IN SUB-SAHARAN AFRICA Am J Trop Med Hyg, August 1, 2004; 71(2_suppl): 41 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Abrams, H. Brown, S. W. Chensue, G. D. H. Turner, E. Tadesse, V. M. Lema, M. E. Molyneux, R. Rochford, S. R. Meshnick, and S. J. Rogerson Host Response to Malaria During Pregnancy: Placental Monocyte Recruitment Is Associated with Elevated {beta} Chemokine Expression J. Immunol., March 1, 2003; 170(5): 2759 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Buseyne, D. Scott-Algara, F. Porrot, B. Corre, N. Bellal, M. Burgard, C. Rouzioux, S. Blanche, and Y. Riviere Frequencies of Ex Vivo-Activated Human Immunodeficiency Virus Type 1-Specific Gamma-Interferon-Producing CD8+ T Cells in Infected Children Correlate Positively with Plasma Viral Load J. Virol., November 13, 2002; 76(24): 12414 - 12422. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Shacklett, K. E. S. Shaw, L. A. Adamson, D. T. Wilkens, C. A. Cox, D. C. Montefiori, M. B. Gardner, P. Sonigo, and P. A. Luciw Live, Attenuated Simian Immunodeficiency Virus SIVmac-M4, with Point Mutations in the Env Transmembrane Protein Intracytoplasmic Domain, Provides Partial Protection from Mucosal Challenge with Pathogenic SIVmac251 J. Virol., October 11, 2002; 76(22): 11365 - 11378. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pedroza-Martins, W. J. Boscardin, D. J. Anisman-Posner, D. Schols, Y. J. Bryson, and C. H. Uittenbogaart Impact of Cytokines on Replication in the Thymus of Primary Human Immunodeficiency Virus Type 1 Isolates from Infants J. Virol., June 14, 2002; 76(14): 6929 - 6943. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hansasuta and S. L Rowland-Jones HIV-1 transmission and acute HIV-1 infection Br. Med. Bull., September 1, 2001; 58(1): 109 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kamin-Lewis, S. F. Abdelwahab, C. Trang, A. Baker, A. L. DeVico, R. C. Gallo, and G. K. Lewis Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta PNAS, July 19, 2001; (2001) 161298998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garzino-Demo, R. B. Moss, J. B. Margolick, F. Cleghorn, A. Sill, W. A. Blattner, F. Cocchi, D. J. Carlo, A. L. DeVico, and R. C. Gallo Spontaneous and antigen-induced production of HIV-inhibitory beta -chemokines are associated with AIDS-free status PNAS, October 12, 1999; 96(21): 11986 - 11991. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kamin-Lewis, S. F. Abdelwahab, C. Trang, A. Baker, A. L. DeVico, R. C. Gallo, and G. K. Lewis Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta PNAS, July 31, 2001; 98(16): 9283 - 9288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |